A Study of Combination Therapies to Treat COVID-19 Infection

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

December 31, 2021

Conditions
COVIDCOVID-19Corona Virus InfectionCoronavirus InfectionCoronavirus Sars-Associated as Cause of Disease Classified ElsewhereCoronavirus-19SARS-CoV 2SARS Pneumonia
Interventions
DRUG

hydroxychloroquine

Treatment with the drug hydroxychloroquine

DRUG

Azithromycin

Treatment with the drug azithromycin

DRUG

Ritonavir

Treatment with the drug ritonavir

DRUG

Lopinavir

Treatment with the drug lopinavir

Trial Locations (1)

93003

ProgenaBiome, Ventura

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Big Corona Ltd.

UNKNOWN

lead

ProgenaBiome

OTHER

NCT04459702 - A Study of Combination Therapies to Treat COVID-19 Infection | Biotech Hunter | Biotech Hunter